Skip to main content
. Author manuscript; available in PMC: 2015 Feb 14.
Published in final edited form as: AJR Am J Roentgenol. 2014 Feb;202(2):336–342. doi: 10.2214/AJR.13.10915

TABLE 4.

Analysis of Effects on Measured Enhancement Detected by Contrast-Enhanced CT Within Nonenhancing Renal Cysts, Controlling for Repeated Measures Within Patients

Covariate Measured Enhancement (Continuous) Measured Enhancement (Categoric, > or ≤ 10 HU)

Univariate p Multivariate p OR (95% CI) Univariate p Multivariate p OR (95% CI)

Patient sex 0.5 0.2
Abdomen cross-sectional area (cm2) 0.9 0.5
Kidney (left or right) 0.3 0.2
Growth (exophytic, endophytic, or mesophytic)a 0.03b NS 0.02b NS
Position (upper, mid, or lower pole)c 0.2 0.2
CT detectors (16 or 64) 0.4 0.3
Tube current (mA) 0.5 0.2
Cyst diameter (mm) < 0.0001b < 0.0001d −0.20 (−0.30 to −0.12) 0.0004b < 0.0004d 0.86 (0.79–0.93)
Cyst area (mm2) 0.0004b NS 0.009b NS
Cyst attenuation unenhanced (HU) 0.2 0.9
Parenchymal attenuation (HU)e 0.03b 0.003d 0.07 (0.03–0.12) 0.02b 0.002d 1.04 (1.01–1.06)

Note—Measured enhancement equals cyst nephrographic phase attenuation minus cyst unenhanced attenuation. Measured enhancement was treated as either a continuous or a categoric dichotomous variable. Dashes indicate that the covariate was not assessed.

OR = odds ratio, NS = not significant in the multivariate model.

a

Cyst growth pattern is a three-level categoric variable.

b

Included in multivariate analysis (p < 0.15).

c

Cyst position in the kidney is a three-level categoric variable.

d

Significant (p < 0.05) in multivariate analysis.

e

Parenchymal attenuation refers to nephrographic phase CT number of the closest normal renal parenchyma adjacent to the reference cyst.